Monday, December 23, 2024
HomeTagsCD8 ImmunoPET Technology

CD8 ImmunoPET Technology

ImaginAb Executes License and Supply Agreement for CD8 ImmunoPET Technology

ImaginAb Inc., a global biotechnology company focused on developing 89Zr crefmirlimab berdoxam imaging agent and radiopharmaceutical therapy (RPT) products, announced the signing of a...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics